These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 33838632)

  • 21. Anti-CRISPR Discovery: Using Magnets to Find Needles in Haystacks.
    Forsberg KJ
    J Mol Biol; 2023 Apr; 435(7):167952. PubMed ID: 36638909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-guided discovery of anti-CRISPR and anti-phage defense proteins.
    Duan N; Hand E; Pheko M; Sharma S; Emiola A
    Nat Commun; 2024 Jan; 15(1):649. PubMed ID: 38245560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Memory of viral infections by CRISPR-Cas adaptive immune systems: acquisition of new information.
    Fineran PC; Charpentier E
    Virology; 2012 Dec; 434(2):202-9. PubMed ID: 23123013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Biology of CRISPR-Cas: Backward and Forward.
    Hille F; Richter H; Wong SP; Bratovič M; Ressel S; Charpentier E
    Cell; 2018 Mar; 172(6):1239-1259. PubMed ID: 29522745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unveil the Secret of the Bacteria and Phage Arms Race.
    Wang Y; Fan H; Tong Y
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of CRISPR-Cas systems by mobile genetic elements.
    Sontheimer EJ; Davidson AR
    Curr Opin Microbiol; 2017 Jun; 37():120-127. PubMed ID: 28668720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BREX is a novel phage resistance system widespread in microbial genomes.
    Goldfarb T; Sberro H; Weinstock E; Cohen O; Doron S; Charpak-Amikam Y; Afik S; Ofir G; Sorek R
    EMBO J; 2015 Jan; 34(2):169-83. PubMed ID: 25452498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The functional aspects of bacterial CRISPR-cas systems and interactions between phages and its bacterial hosts--a review].
    Fu Q; Sun J; Yan Y
    Wei Sheng Wu Xue Bao; 2015 Mar; 55(3):251-7. PubMed ID: 26065266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary Phage Biology: From Classic Models to New Insights.
    Ofir G; Sorek R
    Cell; 2018 Mar; 172(6):1260-1270. PubMed ID: 29522746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (Ph)ighting Phages: How Bacteria Resist Their Parasites.
    Rostøl JT; Marraffini L
    Cell Host Microbe; 2019 Feb; 25(2):184-194. PubMed ID: 30763533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diverse enzymatic activities mediate antiviral immunity in prokaryotes.
    Gao L; Altae-Tran H; Böhning F; Makarova KS; Segel M; Schmid-Burgk JL; Koob J; Wolf YI; Koonin EV; Zhang F
    Science; 2020 Aug; 369(6507):1077-1084. PubMed ID: 32855333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages.
    Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER
    Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the CRISPR-Cas system in bacteriophages active on epidemic strains of Vibrio cholerae in Bangladesh.
    Naser IB; Hoque MM; Nahid MA; Tareq TM; Rocky MK; Faruque SM
    Sci Rep; 2017 Nov; 7(1):14880. PubMed ID: 29093571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. It is unclear how important CRISPR-Cas systems are for protecting natural populations of bacteria against infections by mobile genetic elements.
    Westra ER; Levin BR
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):27777-27785. PubMed ID: 33122438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of Type I-E and I-F CRISPR-Cas Systems in
    Xue C; Sashital DG
    EcoSal Plus; 2019 Feb; 8(2):. PubMed ID: 30724156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The never-ending battle between lactic acid bacteria and their phages.
    Philippe C; Cornuault JK; de Melo AG; Morin-Pelchat R; Jolicoeur AP; Moineau S
    FEMS Microbiol Rev; 2023 Jul; 47(4):. PubMed ID: 37353926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR-Cas10 assisted editing of virulent staphylococcal phages.
    Nayeemul Bari SM; Hatoum-Aslan A
    Methods Enzymol; 2019; 616():385-409. PubMed ID: 30691652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CRISPR: discovery, mechanism and function.
    Pawluk A; Davidson AR; Maxwell KL
    Nat Rev Microbiol; 2018 Jan; 16(1):12-17. PubMed ID: 29062071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BacteRiophage EXclusion (BREX): A novel anti-phage mechanism in the arsenal of bacterial defense system.
    Chaudhary K
    J Cell Physiol; 2018 Feb; 233(2):771-773. PubMed ID: 28444888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why put up with immunity when there is resistance: an excursion into the population and evolutionary dynamics of restriction-modification and CRISPR-Cas.
    Gurney J; Pleška M; Levin BR
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180096. PubMed ID: 30905282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.